Atea Pharmaceuticals
AVIR
AVIR
106 hedge funds and large institutions have $190M invested in Atea Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.33% less ownership
Funds ownership: 61.9% → 61.57% (-0.33%)
Holders
106
Holding in Top 10
1
Calls
$7K
Puts
–
Top Buyers
| 1 | +$679K | |
| 2 | +$514K | |
| 3 | +$501K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$476K |
| 5 |
Two Sigma Investments
New York
|
+$343K |
Top Sellers
| 1 | -$1.73M | |
| 2 | -$890K | |
| 3 | -$819K | |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
-$804K |
| 5 |
D.E. Shaw & Co
New York
|
-$443K |